Ivermectin - a podcast by Rob Mac Sweeney

Prof Alistair Nichol (Dublin & Melbourne) discusses why the REMAP-CAP adaptive platform trial has chosen to investigate ivermectin, given the controversy surrounding this agent.

Further episodes of Critical Care Reviews Podcast

Further podcasts by Rob Mac Sweeney

Website of Rob Mac Sweeney